Purchases and Sales Made in Q1 2022 in Zynerba Pharmaceuticals, Inc. (ZYNE)
This table provides information about the institutional ownership of Zynerba Pharmaceuticals, Inc. (ZYNE) during Q1 2022. The information is specifically focused on institutions that hold shares of Zynerba Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-89.5K- 68.24% |
$164K - $270K
|
41.7K
$0
|
|
|
May 11, 2022
Q1 2022
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-120K- 44.27% |
$219K - $362K
|
151K
$0
|
|
|
May 10, 2022
Q1 2022
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-123K- 9.0% |
$225K - $372K
|
1.25M
$0
|
|
|
May 16, 2022
Q1 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-210K- 56.34% |
$384K - $634K
|
163K
$0
|
|
|
May 13, 2022
Q1 2022
|
ETF Managers Group, LLC
Summit, NJ |
SELL
|
- |
-923K- 20.14% |
$1.69M - $2.79M
|
3.66M
$0
|